149 related articles for article (PubMed ID: 36252336)
1. Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation.
Xie FL; Wang Y; Zhu JW; Xu HH; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2022 Dec; 237():112011. PubMed ID: 36252336
[TBL] [Abstract][Full Text] [Related]
2. DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.
Zhang Y; Zhou Y; Zhang H; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Nov; 224():111580. PubMed ID: 34438219
[TBL] [Abstract][Full Text] [Related]
3. Iridium(III)-BBIP complexes induce apoptosis via PI3K/AKT/mTOR pathway and inhibit A549 lung tumor growth in vivo.
Zhou Y; Bai L; Tian L; Yang L; Zhang H; Zhang Y; Hao J; Gu Y; Liu Y
J Inorg Biochem; 2021 Oct; 223():111550. PubMed ID: 34311319
[TBL] [Abstract][Full Text] [Related]
4. Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway.
Chen J; Liu H; Chen Y; Hu H; Huang C; Wang Y; Liang L; Liu Y
J Inorg Biochem; 2023 Apr; 241():112145. PubMed ID: 36709684
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.
Xie B; Wang Y; Wang D; Xue X; Nie Y
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080200
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway.
Wang J; Liu H; Wu X; Shi C; Li W; Yuan Y; Liu Y; Xing D
J Biol Inorg Chem; 2022 Aug; 27(4-5):455-469. PubMed ID: 35817878
[TBL] [Abstract][Full Text] [Related]
8. Iridium(III) complexes entrapped in liposomes trigger mitochondria-mediated apoptosis and GSDME-mediated pyroptosis.
Zhang H; Liao X; Wu X; Shi C; Zhang Y; Yuan Y; Li W; Wang J; Liu Y
J Inorg Biochem; 2022 Mar; 228():111706. PubMed ID: 35033830
[TBL] [Abstract][Full Text] [Related]
9. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.
Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro.
Xie FL; Huang ZT; Bai L; Zhu JW; Xu HH; Long QQ; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2021 Dec; 225():111603. PubMed ID: 34564032
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation of novel iridium(III) complexes targeting mitochondria toward melanoma B16 cells.
Yuan Y; Zhang Y; Chen J; Huang C; Liu H; Li W; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2023 Feb; 247():115046. PubMed ID: 36577214
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
13. Targeted liposomes encapsulated iridium(III) compound greatly enhance anticancer efficacy and induce cell death via ferroptosis on HepG2 cells.
Chen J; Li W; Li G; Liu X; Huang C; Nie H; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116078. PubMed ID: 38141286
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
16. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
17. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
18. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum.
Wang Y; Li Y; Chen J; Liu H; Zhou Y; Huang C; Liang L; Liu Y; Wang X
J Inorg Biochem; 2023 Jan; 238():112054. PubMed ID: 36335745
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of liposome entrapped iridium(III) complexes toward SGC-7901 cells.
Chen Y; Gu Y; Hu H; Liu H; Li W; Huang C; Chen J; Liang L; Liu Y
J Inorg Biochem; 2023 Apr; 241():112134. PubMed ID: 36706490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]